# Edwards Lifesciences acquires stake in Affluent Medical for €15M

Edwards Lifesciences agreed to pay 15 million euros (about $16.3 million) for a 9.21% equity stake in France's Affluent Medical, including an exclusive option to buy its mitral ring subsidiary and a global license for biomimetic mitral valve replacement technology.

- Type: Acquisition
- Announced: 2024-07-12
- Where: France
- Value: $16.3M (15.0M EUR)
- Status: announced
- Products: mitral ring, biomimetic mitral valve replacement technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md) (acquirer)
- [Affluent Medical](https://endata.com/companies/78572.md) (target)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/edwards-mitral-innovalve-affluent-deals/721359/), 2024-07-15: "In a separate deal announced Friday, Edwards agreed to pay 15 million euros (about $16.3 million) for a stake in France’s Affluent Medical and access to its technologies."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.